Biotechnology to Combat COVID-19 PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Biotechnology to Combat COVID-19 PDF full book. Access full book title Biotechnology to Combat COVID-19 by Megha Agrawal. Download full books in PDF and EPUB format.
Author: Megha Agrawal
Publisher: BoD – Books on Demand
ISBN: 183968626X
Category : Medical
Languages : en
Pages : 646
Get Book
Book Description
This book provides an inclusive and comprehensive discussion of the transmission, science, biology, genome sequencing, diagnostics, and therapeutics of COVID-19. It also discusses public and government health measures and the roles of media as well as the impact of society on the ongoing efforts to combat the global pandemic. It addresses almost every topic that has been studied so far in the research on SARS-CoV-2 to gain insights into the fundamentals of the disease and mitigation strategies. This volume is a useful resource for virologists, epidemiologists, biologists, medical professionals, public health and government professionals, and all global citizens who have endured and battled against the pandemic.
Author: Megha Agrawal
Publisher: BoD – Books on Demand
ISBN: 183968626X
Category : Medical
Languages : en
Pages : 646
Get Book
Book Description
This book provides an inclusive and comprehensive discussion of the transmission, science, biology, genome sequencing, diagnostics, and therapeutics of COVID-19. It also discusses public and government health measures and the roles of media as well as the impact of society on the ongoing efforts to combat the global pandemic. It addresses almost every topic that has been studied so far in the research on SARS-CoV-2 to gain insights into the fundamentals of the disease and mitigation strategies. This volume is a useful resource for virologists, epidemiologists, biologists, medical professionals, public health and government professionals, and all global citizens who have endured and battled against the pandemic.
Author: Sergio Rosales-Mendoza
Publisher: Academic Press
ISBN: 0323902499
Category : Medical
Languages : en
Pages : 411
Get Book
Book Description
Biomedical Innovations to Combat COVID-19 provides an updated overview on the development of vaccines, antiviral drugs and nanomaterials, and diagnostic methods for the fight against COVID-19. Perspectives on such technologies are identified, discussed, and enriched with figures for easy understanding and applicability. Furthermore, it contains basic aspects of virology, immunology, and antiviral drugs that are needed to fully appreciate these innovations. This book is split into four sections: introduction, presenting basic virologic and epidemiological aspects of COVID-19; vaccines against COVID-19, discussing their different types and applications used to develop them; diagnostic approaches for SARS-CoV-2, encompassing advanced sensing and microfluidic-based biosensors; and drug development and delivery, where antivirals based on nanomaterials or drugs are presented. It is a valuable source for virologists, biotechnologists, and members of biomedical field interested in learning more about how novel technologies can be applied to fasten the eradication of the COVID-19 and similar pandemics. Presents updated literature coverage summarizing the most relevant information on COVID-19 Written by experts from diverse scientific domains in order to provide readers with a thorough view on the subject Encompasses tables, figures and information trees especially developed for the book in order to condense and highlight key points for quick reference
Author: Jeremy M. Levin
Publisher: Rosetta Books
ISBN: 0795352980
Category : Business & Economics
Languages : en
Pages : 263
Get Book
Book Description
47 leaders from across the biotechnology industry tell their stories of battling the global scourge of COVID-19. Pandemics have killed at least a half billion people over the past two millennia. But in the age of biotechnology, humanity is no longer defenseless. The biotechnology industry is a diverse community of scientists, doctors, patients, entrepreneurs, investors, bankers, analysts and reporters, all committed to treating and curing disease. Over the past forty years, it has produced medical advances at an electrifying rate. As the COVID-19 pandemic emerged, hundreds of companies quickly pivoted to combating the virus. The contributors to this book offer inside views of this seminal industry, with historical and personal perspectives, lessons learned, and looks into the future. Diverse as these leaders are, they are united by their conviction that science and medicine will light humanity’s way to greater health and longevity.
Author: Dana Barry
Publisher: Springer Nature
ISBN: 9811913560
Category : Science
Languages : en
Pages : 189
Get Book
Book Description
This unique book provides excellent examples of ongoing, leading-edge research related to viruses, especially COVID-19. It is written from the viewpoint of various scientific fields including materials science. It introduces and describes viruses (submicroscopic infectious agents that replicate inside the living cells of an organism), various infections caused by viruses (human to human, human to other organisms to humans, humans to materials to humans, etc.), not only from the viewpoint of medical research but also from other scientific disciplines. A major focus of the book is the COVID-19 virus. Highlighted topics include the evolution of COVID-19, transmission of virus particles through the air, virus spread through various materials, detection of the virus by testing wastewater, the development and testing of vaccines and therapeutic drugs, and the preparation for future viruses and pandemics. This includes reform in funeral services to properly and safely accommodate very large numbers of bodies in a pandemic, like those seen in New York City when it was the epicenter for the virus in the United States. This book serves as an excellent and very informative guide (practical book) for engineers and researchers of various backgrounds and as a great academic textbook.
Author: Jeremy M Levin
Publisher:
ISBN: 9780795352973
Category :
Languages : en
Pages :
Get Book
Book Description
A global, timely calling card for the biotechnology industry, and their efforts going forward during the COVID-19 pandemic. A collection of diverse viewpoints from over 40 thought leaders in the biotech industry.
Author: Debmalya Barh
Publisher: Academic Press
ISBN: 0323986218
Category : Medical
Languages : en
Pages : 464
Get Book
Book Description
The COVID-19 pandemic has affected the entire world in an unprecedented way since 2019. However, novel and innovative applications of various omics, computational, and smart technologies have helped manage the pandemic of the 21st century in a very effective manner. Omics approaches and technologies in COVID-19 presents up-to-date knowledge on omics, genetic engineering, mathematical and computational approaches, and advanced technologies in the diagnosis, prevention, monitoring, and management of COVID-19. This book contains 26 chapters written by academic and industry experts from more than 15 countries. Split into three sections (Omics; Artificial Intelligence and Bioinformatics; and Smart and Emerging Technologies), it brings an overview of novel technologies under omics such as, genomic, metagenomic, pangenomic, metabolomics and proteomics in COVID-19. In addition, it discusses hostpathogen interactions and interactomics, management options, application of genetic engineering, mathematical modeling andsimulations, systems biology, and bioinformatics approaches in COVID-19 drug discovery and vaccine development. This is a valuable resource for students, biotechnologists, bioinformaticians, virologists, clinicians, and pharmaceutical, biomedical, and healthcare industry people who want to understand the promising omics and other technologies used in combating COVID-19 from various aspects. Provides novel technologies for rapid diagnostics, drug discovery, vaccine development, monitoring, prediction of future waves, etc. Describes various omics applications including genomics, metagenomics, epigenomics, nutrigenomics, transcriptomics,miRNAomics, proteomics, metabolomics, phenomics, multiomics, etc., in COVID-19 Presents applications of genetic engineering, CRISPR, artificial intelligence, mathematical and in silico modeling, systems biology,and other computational approaches in COVID-19 Discusses emerging, digital, and smart technologies for the monitoring and management of COVID-19
Author: Neeraj Dwivedi
Publisher: CRC Press
ISBN: 1000952312
Category : Technology & Engineering
Languages : en
Pages : 158
Get Book
Book Description
This book covers the application of emerging materials to combat coronavirus. It discusses various physicochemical and biomedical characteristics of 2D materials, such as graphene, MXenes, and their various other derivatives, followed by proposal of how such materials can be used to design and develop several systems capable of fighting infectious diseases like coronavirus. It also covers fundamental and product developments based on MXene and graphene-based materials using emerging 3D printing process and other pertinent aspects. Features: Focusses on COVID-19 from cross-disciplinary approach, especially biophysical management of the virus. Discusses emerging 2D materials such as MXene and graphene to combat coronavirus. Reviews development of PPEs, sterilizers, foams, antimicrobial surfaces, biosensors from materials science perspective. Explores pertinent fundamental mechanisms to develop structure–property relationships. Examines cytotoxicity and biocompatibility of the discussed 2D materials. This book is aimed at researchers and graduate students in biotechnology, biomedical engineering, chemical engineering, and materials science.
Author: Jasper Becker
Publisher: Oxford University Press
ISBN: 1787386120
Category : Political Science
Languages : en
Pages : 344
Get Book
Book Description
What might COVID-19 mean for, and reveal about, China's place in the world? The coronavirus pandemic started in Wuhan, home to the leading lab studying the SARS virus and bats. Was that pure coincidence? This book explores what we know, and still don't know, about the origins of COVID-19, and how it was handled in China. We may never get all the answers, but much is already clear: China's record as the origin of earlier pandemics, and its struggle to bring contagious diseases under control; its history as both a victim of biological warfare and a developer of deadly bioweapons. When Covid broke out, Wuhan was building science parks to realise Beijing's ambitions in biotech research. Whoever achieves global leadership of the gene-editing industry stands to harvest great power and wealth. China has already challenged Western technological supremacy with 5G and in other industries. Yet this tiny, invisible virus has cruelly exposed a critical flaw in the Chinese political system: obsessive secrecy. The West wanted to trust the PRC, hoping that, as it prospered, it would become an open society. Made in China reveals how Beijing's leaders have betrayed that trust.
Author: Donald L. Drakeman
Publisher: Oxford University Press
ISBN: 0195084004
Category : Biotechnology industries
Languages : en
Pages : 241
Get Book
Book Description
"Beginning in the 1970s, several scientific breakthroughs promised to transform the creation of new medicines. As investors sought to capitalize on these Nobel Prize-winning discoveries, the biotech industry grew to thousands of small companies around the world. Each sought to emulate what the major pharmaceutical companies had been doing for a century or more, but without the advantages of scale, scope, experience, and massive resources. How could a large collection of small companies, most with fewer than 50 employees, compete in one of the world's most breathtakingly expensive and highly regulated industries? This book shows how biotech companies have met the challenge by creating nearly 40% more of the most important treatments for unmet medical needs. Moreover, they have done so with much lower overall costs. The book focuses on both the companies themselves and the broader biotech ecosystem that supports them. Its portrait of the crucial roles played by academic research, venture capital, contract research organizations, the capital markets, and pharmaceutical companies shows how a supportive environment enabled the entrepreneurial biotech industry to create novel medicines with unprecedented efficiency. In doing so, it also offers insights for any industry seeking to innovate in uncertain and ambiguous conditions. Looking to the future, it concludes that biomedical research will continue to be most effective in the hands of a large group of small companies as long as national healthcare policies allow the rest of the ecosystem to continue to thrive"--
Author: Joe Miller
Publisher: St. Martin's Press
ISBN: 1250280370
Category : Biography & Autobiography
Languages : en
Pages : 272
Get Book
Book Description
Winners of the Paul Ehrlich Prize The dramatic story of the married scientists who founded BioNTech and developed the first vaccine against COVID-19. Nobody thought it was possible. In mid-January 2020, Ugur Sahin told Özlem Türeci, his wife and decades-long research partner, that a vaccine against what would soon be known as COVID-19 could be developed and safely injected into the arms of millions before the end of the year. His confidence was built upon almost thirty years of research. While working to revolutionize the way that cancerous tumors are treated, the couple had explored a volatile and overlooked molecule called messenger RNA; they believed it could be harnessed to redirect the immune system's forces against any number of diseases. As the founders of BioNTech, they faced widespread skepticism from the scientific community at first; but by the time Sars-Cov-2 was discovered in Wuhan, China, BioNTech was prepared to deploy cutting edge technology and create the world’s first clinically approved inoculation for the coronavirus. The Vaccine draws back the curtain on one of the most important medical breakthroughs of our age; it will reveal how Doctors Sahin and Türeci were able to develop twenty vaccine candidates within weeks, convince Big Pharma to support their ambitious project, navigate political interference from the Trump administration and the European Union, and provide more than three billion doses of the Pfizer/BioNTech vaccine to countries around the world in record time. Written by Joe Miller—the Financial Times’ Frankfurt correspondent who covered BioNTech’s COVID-19 project in real time—with contributions from Sahin and Türeci, as well as interviews with more than sixty scientists, politicians, public health officials, and BioNTech staff, the book covers key events throughout the extraordinary year, as well as exploring the scientific, economic, and personal background of each medical innovation. Crafted to be both completely accessible to the average reader and filled with details that will fascinate seasoned microbiologists, The Vaccine explains the science behind the breakthrough, at a time when public confidence in vaccine safety and efficacy is crucial to bringing an end to this pandemic.
